List of Tables
    Table 1. Poxviridae Infections Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Poxviridae Infections Drug Market Trends
    Table 3. Poxviridae Infections Drug Market Drivers
    Table 4. Poxviridae Infections Drug Market Challenges
    Table 5. Poxviridae Infections Drug Market Restraints
    Table 6. Global Poxviridae Infections Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Poxviridae Infections Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Poxviridae Infections Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Poxviridae Infections Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Poxviridae Infections Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Poxviridae Infections Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Poxviridae Infections Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Poxviridae Infections Drug Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Poxviridae Infections Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Poxviridae Infections Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Poxviridae Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Poxviridae Infections Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poxviridae Infections Drug as of 2021)
    Table 18. Top Players of Poxviridae Infections Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Poxviridae Infections Drug Product Type
    Table 20. Date of International Manufacturers Enter into Poxviridae Infections Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Poxviridae Infections Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Poxviridae Infections Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Poxviridae Infections Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Poxviridae Infections Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Poxviridae Infections Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Poxviridae Infections Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Poxviridae Infections Drug Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Poxviridae Infections Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Poxviridae Infections Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Poxviridae Infections Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Poxviridae Infections Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Poxviridae Infections Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Poxviridae Infections Drug Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Poxviridae Infections Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Poxviridae Infections Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Poxviridae Infections Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Poxviridae Infections Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Poxviridae Infections Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Poxviridae Infections Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Poxviridae Infections Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bavarian Nordic A/S Corporation Information
    Table 43. Bavarian Nordic A/S Description and Business Overview
    Table 44. Bavarian Nordic A/S Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Bavarian Nordic A/S Poxviridae Infections Drug Product
    Table 46. Bavarian Nordic A/S Recent Development
    Table 47. BioFactura, Inc. Corporation Information
    Table 48. BioFactura, Inc. Description and Business Overview
    Table 49. BioFactura, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. BioFactura, Inc. Product
    Table 51. BioFactura, Inc. Recent Development
    Table 52. CEL-SCI Corporation Corporation Information
    Table 53. CEL-SCI Corporation Description and Business Overview
    Table 54. CEL-SCI Corporation Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. CEL-SCI Corporation Product
    Table 56. CEL-SCI Corporation Recent Development
    Table 57. Chimerix, Inc. Corporation Information
    Table 58. Chimerix, Inc. Description and Business Overview
    Table 59. Chimerix, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Chimerix, Inc. Product
    Table 61. Chimerix, Inc. Recent Development
    Table 62. China Biologic Products, Inc. Corporation Information
    Table 63. China Biologic Products, Inc. Description and Business Overview
    Table 64. China Biologic Products, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. China Biologic Products, Inc. Product
    Table 66. China Biologic Products, Inc. Recent Development
    Table 67. CJ HealthCare Corp. Corporation Information
    Table 68. CJ HealthCare Corp. Description and Business Overview
    Table 69. CJ HealthCare Corp. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. CJ HealthCare Corp. Product
    Table 71. CJ HealthCare Corp. Recent Development
    Table 72. EpiVax, Inc. Corporation Information
    Table 73. EpiVax, Inc. Description and Business Overview
    Table 74. EpiVax, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. EpiVax, Inc. Product
    Table 76. EpiVax, Inc. Recent Development
    Table 77. N & N Pharmaceuticals Inc. Corporation Information
    Table 78. N & N Pharmaceuticals Inc. Description and Business Overview
    Table 79. N & N Pharmaceuticals Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. N & N Pharmaceuticals Inc. Product
    Table 81. N & N Pharmaceuticals Inc. Recent Development
    Table 82. SIGA Technologies, Inc. Corporation Information
    Table 83. SIGA Technologies, Inc. Description and Business Overview
    Table 84. SIGA Technologies, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. SIGA Technologies, Inc. Product
    Table 86. SIGA Technologies, Inc. Recent Development
    Table 87. Takeda Pharmaceutical Company Limited Corporation Information
    Table 88. Takeda Pharmaceutical Company Limited Description and Business Overview
    Table 89. Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Takeda Pharmaceutical Company Limited Product
    Table 91. Takeda Pharmaceutical Company Limited Recent Development
    Table 92. Tonix Pharmaceuticals Holding Corp. Corporation Information
    Table 93. Tonix Pharmaceuticals Holding Corp. Description and Business Overview
    Table 94. Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Tonix Pharmaceuticals Holding Corp. Product
    Table 96. Tonix Pharmaceuticals Holding Corp. Recent Development
    Table 97. Verrica Pharmaceuticals Inc. Corporation Information
    Table 98. Verrica Pharmaceuticals Inc. Description and Business Overview
    Table 99. Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Verrica Pharmaceuticals Inc. Product
    Table 101. Verrica Pharmaceuticals Inc. Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Poxviridae Infections Drug Customers List
    Table 105. Poxviridae Infections Drug Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Poxviridae Infections Drug Product Picture
    Figure 2. Global Poxviridae Infections Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Poxviridae Infections Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Poxviridae Infections Drug Sales 2017-2028 (K Pcs)
    Figure 5. United States Poxviridae Infections Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Poxviridae Infections Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Poxviridae Infections Drug Sales 2017-2028 (K Pcs)
    Figure 8. United States Poxviridae Infections Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Poxviridae Infections Drug Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Poxviridae Infections Drug Report Years Considered
    Figure 11. Product Picture of CJ-40011
    Figure 12. Product Picture of 24a
    Figure 13. Product Picture of BA-368
    Figure 14. Product Picture of Others
    Figure 15. Global Poxviridae Infections Drug Market Share by Type in 2022 & 2028
    Figure 16. Global Poxviridae Infections Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Poxviridae Infections Drug Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Poxviridae Infections Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 19. Global Poxviridae Infections Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Poxviridae Infections Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 21. United States Poxviridae Infections Drug Market Share by Type in 2022 & 2028
    Figure 22. United States Poxviridae Infections Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Poxviridae Infections Drug Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Poxviridae Infections Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 25. United States Poxviridae Infections Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Poxviridae Infections Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 27. Product Picture of Hospital
    Figure 28. Product Picture of Clinic
    Figure 29. Product Picture of Others
    Figure 30. Global Poxviridae Infections Drug Market Share by Application in 2022 & 2028
    Figure 31. Global Poxviridae Infections Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Poxviridae Infections Drug Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Poxviridae Infections Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 34. Global Poxviridae Infections Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Poxviridae Infections Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 36. United States Poxviridae Infections Drug Market Share by Application in 2022 & 2028
    Figure 37. United States Poxviridae Infections Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Poxviridae Infections Drug Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Poxviridae Infections Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 40. United States Poxviridae Infections Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Poxviridae Infections Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 42. North America Poxviridae Infections Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 43. North America Poxviridae Infections Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Poxviridae Infections Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. Europe Poxviridae Infections Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Poxviridae Infections Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 54. Asia-Pacific Poxviridae Infections Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Poxviridae Infections Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 66. Latin America Poxviridae Infections Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Poxviridae Infections Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Middle East & Africa Poxviridae Infections Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Poxviridae Infections Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Poxviridae Infections Drug Value Chain
    Figure 76. Poxviridae Infections Drug Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed